Yi Liu Kai
Directeur/Membre du Conseil chez Bristol-Myers Squibb FCT bêta, Inc.
Postes actifs de Yi Liu Kai
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 05/11/2021 | - |
Historique de carrière de Yi Liu Kai
Statistiques
Internationale
| Canada | 2 |
Opérationnelle
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |
- Bourse
- Insiders
- Yi Liu Kai
- Expérience
